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Abstract:
Uterine tumors resembling ovarian sex cord tumors (UTROSCTs) are rare uterine neoplasms of 
uncertain etiology that resemble the well-known sex cord tumors of the ovary and display a combined 
sex cord, epithelial, and smooth muscle immunophenotype. Most tumors are associated with a benign 
clinical course. Here, we report the first cytological description of uterine UTROSCTs in liquid-based 
cervical cytology. A 56-year-old menopausal woman who complained of vaginal bleeding was admitted 
to the emergency room and was discovered to have a uterine intraluminal polypoid mass protruding 
through the vagina. A Papanicolaou (Pap) test was performed, and the liquid-based cytology (LBC) 
(ThinPrep) preparation showed isolated tumor cells with scant cytoplasm and slightly irregular, ovoid 
nuclei with fine chromatin and small nucleoli. Mitotic figures were not observed. The background was 
hemorrhagic without necrosis. These features raised the differential diagnosis of cervical 
adenocarcinoma, endometrioid adenocarcinoma and, less likely, an epithelial component of a malignant 
mixed Müllerian tumor (MMMT) (as clinically suspected). Polypectomy and subsequent hysterectomy 
were performed, and the final histological evaluation identified a UTROSCT. This is the first case 
describing the cytological features of a UTROSCT consisting of malignant-appearing 
adenocarcinomatous cells in LBC Pap smears. This diagnostic possibility, albeit rare, should be included 
in the differential diagnosis when isolated atypical cells are seen in women in the above scenario. As 
these features are not specific, they may result in misinterpretation with tumors that are more common 
and aggressive.
Key words: liquid-based cytology, Pap smears, uterine tumor resembling ovarian sex-cord tumor, 
UTROSCT, differential diagnosis.
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Introduction
Uterine tumors resembling ovarian sex-cord tumors (UTROSCTs) are rare uterine neoplasms that were 
first reported by Clement and Scully in 1976.1 Since then, this tumor entity has been delineated into two 
distinct subtypes. Type I tumors, known as endometrial stromal tumors with sex cord-like elements 
(ESTSCLEs), have been recognized to have malignant potential, as they have a conventional component 
of endometrial stromal neoplasia that, if invasive, determines the prognosis of the patient. Type II tumors 
comprise tumors composed exclusively of sex cord-like elements, and most are considered to behave in 
a benign fashion, with some showing metastasis and recurrence.2 The last World Health Organization 
(WHO) Classification of Tumors of the Female Reproductive Organs placed UTROSCTs in the category 
of ‘endometrial stromal and related neoplasms’.3 Approximately 43 cases have been reported 
histologically in the literature.4,5 However, only two reports have described the cytological features with 
touch imprint,6,7 and none have been described with conventional or liquid-based cytology (LBC). 
Current cervical screening programs using LBC increase the possibility of encountering UTROSCTs in 
such specimens, thus leading to potential diagnostic pitfalls. 
Here, we report a unique case of a UTROSCT with preoperative LBC, in which the diagnosis was not 
expected. The cytological features and the differential cytological diagnosis are discussed.
Case report
A 56-year-old menopausal woman with no particular medical history presented to her family 
gynecologist with vaginal bleeding. During the gynecological examination, a hemorrhagic and necrotic 
mass protruding through the vagina was noted, and the cervix was difficult to reach behind the mass. 
The patient was transferred to our gynecological emergency department for further examination, and a 
Papanicolaou (Pap) test was initially performed. As the patient presented with severe menorrhagia, an 
excision of the vaginal mass was first performed. During surgery, a necrotic mass (7 cm) was observed 
inside the vagina, with a pedicle coming from the endocervix. Excision of the mass and hemostasis were 
performed via a vaginal approach. The protruded mass was sent for pathology. The surgery was followed 
by a pelvic MRI. This approach demonstrated a residual solid mass of 2.6 cm originating from the right 
uterine wall and protruding inside the lumen (Figure 1A and 1B). The lesion appeared to be isosignal to 
the myometrium on T1- and T2-weighted imaging with homogeneous enhancement after a gadolinium 
injection. On diffusion-weighted planes, we observed a restricted diffusion limited to the pediculated 
component (Supplemental Figure 1). The uterine wall was thus not suspected to be invaded. Apart from 
an obstructive hematometra and some physiological free pelvic fluid, no other abnormalities were seen. 
A secondary hysterectomy and bilateral salpingo-oophorectomy were performed following the final 
pathological report.
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Cytological Findings
The cytological specimen was processed using the ThinPrep technique (Hologic Inc., Marlborough, 
Mass., USA). The Pap test showed a hemorrhagic background with atypical cells. The cells were often 
isolated (Figure 1C) or arranged in small clusters (Figure 1D), with scant cytoplasm. The nuclei were 
slightly irregular and ovoid, with fine granular chromatin and conspicuous nucleoli. Mitotic figures or 
necrosis were not observed. These cells were more consistent with cells of glandular origin; thus, the 
preliminary diagnosis was that of “atypical glandular cells consistent with adenocarcinoma, NOS”.
Histological findings:
Macroscopically, the mass was fragmented and hemorrhagic. Microscopic examination showed a tumor 
organized in papillary structures as well as slit-likes spaces, trabeculae and solid areas (Figure 1E). The 
tumor cells were small and regular with eosinophilic cytoplasm, although some had clear cytoplasm. 
Frequent dense eosinophilic intracytoplasmic (rhabdoid) inclusions were noted (Figure 1F). The nuclei 
were oval, with finely distributed chromatin and one clearly visible nucleolus, and the overall 
appearance was bland and monotonous (Figure 1E, inset). Rare mitoses were found. The intervening 
stroma was scant and fibroblastic, with associated scattered foamy histiocytes.
The tumor cells showed diffuse positivity for CKAE1/AE (Figure 1F, upper right inset) and estrogen 
receptors, patchy staining for smooth muscle markers (AML and desmin), and focal expression of sex 
cord markers (calretinin, inhibin (Figure 1F, lower right inset), MelanA, CD99, CD56, and WT1). No 
staining was observed for neuroendocrine markers (synaptophysin and chromogranin), PAX8, S100, 
HMB-45, EMA, CK7, CK20, CD117, CD30, CEA, or glypican3. The final diagnosis was a UTROSCT. 
A hysterectomy showed that the tumor originated from the right uterine wall and protruded into the 
cavity. The greatest dimension of the tumor was 2.6 cm. The cut surface was yellowish with hemorrhagic 
areas. Microscopically, the tumor showed similar histological features. There was neither myometrial 
invasion nor cervical involvement, and the peritoneal lavage did not exhibit tumor cells. The patient 
remained under radiological surveillance with a short follow up (4 months). 
Discussion: 
A UTROSCT is an uncommon uterine neoplasm that accounts for less than 0.5% of all uterine 
malignancies and 10-15% of mesenchymal uterine malignancies. Most UTROSCTs exhibit benign 
behavior but occasionally recur or metastasize; hence, these tumors are considered neoplasms of 
uncertain malignant potential that rarely behave in an aggressive manner.5,8 Histogenesis remains 
uncertain, and postulated theories include derivation from ovarian sex cord cells that have been 
displaced during embryogenesis, derivation from uncommitted mesenchymal stem cells, and 
overgrowth of sex cord elements within an endometrial stromal neoplasm or an adenosarcoma.9 The last 
hypothesis appears unlikely because UTROSCTs lack JAZF1-JJAZ1 gene fusion or PFH1 
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rearrangement, in contrast to endometrial stromal tumors with or without sex cord elements, suggesting 
an independent origin.10 The tumors are often polypoid and submucosal but can be intramyometrial, 
subserosal, or cervical.11 Given the rarity of this tumor, the diagnosis of UTROSCT is usually made 
postoperatively via histopathological analysis. Morphologically, these tumors closely resemble the 
morphological spectrum of ovarian sex cord-stromal tumors, with organization in sheets, cords, nests, 
trabeculae or tubules. Neoplastic cells are epithelioid with scant eosinophilic, clear cytoplasm or, rarely, 
with a rhabdoid appearance.12 The nuclei are bland with minimal atypia and rare mitoses. These tumors 
characteristically exhibit polyphenotypic immunophenotypes with coexpression of cytokeratins, smooth 
muscle markers, hormone receptors, and markers, which are commonly positive in ovarian sex cord-
stromal neoplasms.12,13
We could find only 2 cases in the literature that described cytological features obtained by touch imprint. 
Nishikimi et al. reported the intraoperative touch imprint of ESTSCLEs.6 Cytological examination 
revealed abundant hyaline-like substances and tumor cells aligned in a cord or glandular form, with 
scant cytoplasm and ovoid-to-spindle-shaped nuclei with little atypia. More recently, Kondo et al. 
described stump smears from resected lung metastases of a UTROSCT.7 In their case, imprint cytology 
of the tumor showed round to short spindle-shaped cells with bare nuclei and no atypia. These cells were 
organized in diverse patterns: isolated, scattered or in sheets with poor cohesion; cords or glandular 
forms were not seen. 
In the present case, however, cytological examination demonstrated neoplastic small epithelial cells that 
were isolated or in clustered formation. At first glance, these cells appeared slightly atypical: scant 
cytoplasm, ovoid nuclei with nuclear membrane irregularities, fine chromatin and conspicuous nucleoli 
(Figure 1C). No mitoses or necrosis were seen, and the background was clean. The abundance of cells 
present and the clinical presentation of a protruding mass into the uterine cavity were all together 
suspicious for us in the sense of a neoplasm. Therefore, the diagnosis of atypical glandular cells 
consistent with well-differentiated adenocarcinoma was first suspected. In the differential diagnosis, we 
suggested the possibility of cervical adenocarcinoma or an epithelial component of an MMMT. 
However, retrospectively, large sheets of glandular cells or crowded groups of tumor cells with feathery 
edges were not present. Clinical presentation with a necrotic mass protruding in the vaginal cavity raises 
the possibility of a diagnosis of MMMT.14 In fact, the sarcomatous component does not easily shed, and 
Pap tests may only show the malignant epithelial component.15 In the present case, neoplastic cells could 
represent an epithelial component. However, the morphological characteristics of endometrial 
adenocarcinoma were missing. There were no chromatin abnormalities; additionally, macronucleoli are 
uncommon in this entity, and watery diathesis is frequently seen (Table 1). Moreover, tumor diathesis, 
which is a characteristic cytological finding of MMMT, was not present.
In conclusion, we describe the first case of a UTROSCT on preoperative LBC. Pap tests usually cannot 
detect mesenchymal tumors of the female genital tract since characteristic cells rarely exfoliate. When 
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exfoliation occurs due to several factors, such as necrosis, ulceration, and tumor location, as in the 
present case, tumor cells can be recognized but are difficult to classify by cytology alone. UTROSCTs 
in a Pap test could give rise to important diagnostic pitfalls. Cytopathologists should include this entity 
in the differential diagnosis in cases that contain isolated, mildly atypical cells without other cytological 
findings oriented to more common malignant diagnosis and in the presence of characteristic cytological 
findings. Indeed, the distinction among other malignant tumors is important because the postoperative 
management of a UTROSCT is different, as this tumor has a benign course with limited potential for 
recurrence.5,16
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Table 1. Cytomorphological features of uterine tumors resembling ovarian sex cord tumors 
(UTROSCTs) and differential diagnosis.
Uterine tumors resembling 
ovarian sex cord tumors 
(UTROSCTs)
Endocervical 
adenocarcinoma
Endometrial 
adenocarcinoma 
(serous and endometrioid)
Architecture Isolated or poor cohesion. 
Rosette-like or trabecular 
arrangement (touch imprint)
Sheets, feathering, 
marked cellular 
crowding
Small cluster, spheres
Cells Medium sized, round Abundant endocervical 
cells, columnar 
Sparse, round 
Cytoplasm Scanty Abundant, foamy or 
granular 
Scant or abundant, vacuolated 
and cytoplasmic neutrophils
Nuclei Finely granular chromatin, 
no mitosis
Large, pale or 
hyperchromatic
hyperchromatic
Nucleoli Sometimes one, prominent Multiple, large Single, prominent
N/C ratio High High High
Background Clear Coarse tumor diathesis Histiocytes, watery tumor 
diathesis
IHC, positive CK, hormone receptors, 
smooth muscle and sex
cord-like markers (inhibin, 
calretinine)
CEA, p16 Vimentin, hormone receptors.
IHC, negative hormone receptors, sex
cord-like and smooth 
muscle markers
sex
cord-like and smooth muscle 
markers
Molecular 
findings
Lacks FOXL2 and DICER1 
mutations. 
No JAZF1-SUZ12 fusion 
No PHF1 gene 
rearrangements
POLE (ultramutated), MSI 
(hypermutated), copy-number 
low (endometrioid), copy-
number high (serous-like)
Legend: UTROSCTs: uterine tumors resembling ovarian sex cord tumors; CK: cytokeratin; N/C: 
nuclear/cytoplasmic; IHC: immunohistochemistry.
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Radiological, cytological, histological and immunohistochemical aspects of UTROSCT. A: Pelvic MRI with 
vaginal ultrasound gel filling in T2-weighted transverse and (B) sagittal planes. A residual broad-based solid 
mass of 2.6 cm is seen (white arrowheads) originating from the right uterine wall and protruding inside the 
uterine cavity. The cavity is dilated by an organized hematometra, which partially protrude through the 
cervix. Pelvic free fluid is also present. C: Pap test demonstrated isolated atypical cells or in some clusters 
(D) with scanty cytoplasm, oval nuclei with fine chromatin and conspicuous nucleoli (C and D, liquid-based 
cytology, Papanicolaou staining, x200). E: Histologically, a uniform population of tumor cells organized in 
trabeculae or solid areas with occasional round and slit-likes spaces was present (hematoxylin and eosin 
staining, x100). E, inset: Tumor cells were small with oval nuclei with one clearly visible nucleolus 
(hematoxylin and eosin staining, x400). F: A different area of the tumor showed cells with rhabdoid features 
(hematoxylin and eosin staining, x400). F, upper right inset: immunohistochemical expression of cytokeratin 
AE1/AE3 and (F, lower right inset) of Alpha-inhibin by tumor cells (x100). 
182x274mm (300 x 300 DPI) 
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T1-weighted post-gadolinium transverse (A) and diffusion-weighted transverse (B, b = 800) images. After 
injection (A), there is a homogeneous enhancement of the lesion, equal to that of the adjacent uterine wall, 
but well circumscribed restricted diffusion (B) limited to the pediculated component. 
338x166mm (300 x 300 DPI) 
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